(navigation image)
Home American Libraries | Canadian Libraries | Universal Library | Community Texts | Project Gutenberg | Children's Library | Biodiversity Heritage Library | Additional Collections
Search: Advanced Search
Anonymous User (login or join us)
Upload
See other formats

Full text of "Regenerative Medicine And Stem Cells Partnering Terms And Agreements"

Regenerative Medicine and Stem Ceils Partnering Terms and Agreements 

Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an 
email on sales@reportsandreports.com with (Regenerative Medicine and Stem 
Cells Market) / report name in subject line and your contact details. 

The Regenerative Medicine and Stem Cells Partnering Terms and Agreements report 
provides comprehensive understanding and unprecedented access to the Regenerative 
medicine and Stem cells partnering deals and agreements entered into by the worlds 
leading healthcare companies. 

• Trends in regenerative medicine and stem cells deals 

• Deal terms analysis 

• Partnering agreement structure 

• Partnering contract documents 

• Top deals by value 

• Most active dealmakers 

• Average deal terms for regenerative medicine and stem cells 
Complete report of 787 Pages is available @ 

http://www.reportsnreports.com/reports/219403-regenerative-medicine-and- 
stem-cells-partnering-terms-and-agreements.html . 

The report provides a detailed understanding and analysis of how and why companies enter 
regenerative medicine and stem cells partnering deals. The majority of deals are 
development stage whereby the licensee obtains a right or an option right to license the 
licensors regenerative medicine and stem cells technology. These deals tend to be 
multicomponent, starting with collaborative R&D, and commercialization of outcomes. 

This report provides details of the latest regenerative medicine and stem cells agreements 
including cell therapy agreements announced in the healthcare sector. 

Understanding the flexibility of a prospective partner's negotiated deals terms provides 
critical insight into the negotiation process in terms of what you can expect to achieve 
during the negotiation of terms. Whilst many smaller companies will be seeking details of 
the payments clauses, the devil is in the detail in terms of how payments are triggered - 
contract documents provide this insight where press releases and databases do not. 

This report contains a comprehensive listing of all regenerative medicine and stem cells 
partnering deals announced since 2008 including financial terms where available including 



Regenerative Medicine and Stem Cells Partnering Terms and Agreements 





over 550 links to online deal records as disclosed by the deal parties. In addition, where 
available, records include contract documents as submitted to the Securities Exchange 
Commission by companies and their partners. 

Inquiry Before Buying on this Report @ 

http://www.reportsnreports.com/contacts/discount.aspx?name= 219403 . 

The initial chapters of this report provide an orientation of drug dealmaking and business 
activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an 
overview of the trends in regenerative medicine and stem cells dealmaking since 2009, 
including details of average headline, upfront, milestone and royalty terms. 

Chapter 3 provides a review of the leading regenerative medicine and stem cells deals 
since 2009. Deals are listed by headline value, signed by bigpharma, most active 
bigpharma, and most active of all biopharma companies. Where the deal has an agreement 
contract published at the SEC a link provides online access to the contract. 

Chapter 4 provides a comprehensive listing of the top 50 bigpharma companies with a brief 
summary followed by a comprehensive listing of regenerative medicine and stem cells deals, 
as well as contract documents available in the public domain. Where available, each deal 
title links via Weblink to an online version of the actual contract document, providing easy 
access to each contract document on demand. 

Chapter 5 provides a comprehensive and detailed review of regenerative medicine and 
stem cells partnering deals signed and announced since 2009, where a contract document is 
available in the public domain. The chapter is organized by stage of development at signing, 
deal type (collaborative R&D, co-promotion, licensing etc), specific therapy focus and 
specific technology type . Each deal title links via Weblink to an online version of the deal 
record and where available, the contract document, providing easy access to each contract 
document on demand. 

Buy a copy of report 

@ http://www.reportsnreports.com/purchase.aspx?name=219403 . 
Key benefits 

• In-depth understanding of regenerative medicine and stem cells deal trends since 
2009 

• Access to headline, upfront, milestone and royalty data 

• Analysis of the structure of regenerative medicine and stem cells agreements with 
numerous real life case studies 

• Comprehensive access to over 1500 actual regenerative medicine and stem cells 
contracts entered into by the world's biopharma companies 

• Detailed access to actual regenerative medicine and stem cells contracts enter into 
by the leading fifty bigpharma companies 



Regenerative Medicine and Stem Cells Partnering Terms and Agreements 





! 


) D 


■ 




veportsnKeports 









• Insight into the terms included in a regenerative medicine and stem cells agreement, 
together with real world clause examples 

• Understand the key deal terms companies have agreed in previous deals 

• Undertake due diligence to assess suitability of your proposed deal terms for partner 
companies 

Table of Contents 

Executive Summary 

Chapter 1 - Introduction 

Chapter 2 - Trends in regenerative medicine and stem cells dealmaking 

Chapter 3 - Leading regenerative medicine and stem cells deals 

Chapter 4 - Bigpharma regenerative medicine and stem cells deals 

Chapter 5 - Regenerative medicine and stem cells partnering contracts directory 

Chapter 6 - Regenerative medicine and stem cells dealmaking by technology type 

Inquire Disocunt @ 

http://www.reportsnreports.com/contacts/discount.aspx?name= 219403 . 

Contact sales@reportsandreports.com / Call +1 888 391 5441 for further 
information on "Regenerative Medicine and Stem Cells Partnering Terms and 
Agreements" report OR for any other market research and intelligence needs you 
may have for your business. 



Regenerative Medicine and Stem Cells Partnering Terms and Agreements